The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Molecular basis for catecholaminergic neuron diversity
Open accessAbstract
Catecholaminergic neurons control diverse cognitive, motor, and endocrine functions and are associated with multiple psychiatric and neurodegenerative disorders. We present global gene-expression profiles that define the four major classes of dopaminergic (DA) and noradrenergic neurons in the brain. Hypothalamic DA neurons and noradrenergic neurons in the locus coeruleus display distinct group-specific signatures of transporters, channels, transcription, plasticity, axon-guidance, and survival factors. In contrast, the transcriptomes of midbrain DA neurons of the substantia nigra and the ventral tegmental area are closely related with <1% of differentially expressed genes. Transcripts implicated in neural plasticity and survival are enriched in ventral tegmental area neurons, consistent with their role in schizophrenia and addiction and their decreased vulnerability in Parkinson's disease. The molecular profiles presented provide a basis for understanding the common and population-specific properties of catecholaminergic neurons and will facilitate the development of selective drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bulk profiling experiments comparing SNc and VTA neurons did indeed yield some interesting gene expression differences [6–9], but suffered from the caveat that they could not distinguish heterogeneous populations within each anatomical cluster.”
From Classification of midbrain dopamine neurons using single-cell gene expression profiling approaches (2020) · cites this paper as [6]
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
Handbook of Chemical Neuroanatomy
Stern, C. D. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90021-5 · Cited by 4,160
The Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,588
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,674
Flagged first, then by citations
Research works printed but not linked: 2
- Dahlstroem, A. & Fuxe, K. (1964) Acta Physiol. Scand. Suppl. 232, 1–55.
- Holzschuh, J., Barrallo-Gimeno, A., Ettl, A. K., Durr, K., Knapik, E. W. & Driever, W. (2003) Development (Cambridge, U.K.) 130, 5741–5754.
Cited by
Sorted by citations
The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
Xicoy, H., Wieringa, B., & Martens, G. J. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0149-0 · Cited by 1,036
The reticular-activating hypofrontality (RAH) model of acute exercise
Dietrich, A., & Audiffren, M. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.02.001 · Cited by 365
Dissecting the diversity of midbrain dopamine neurons
Roeper, J. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.03.003 · Cited by 395
Chung, C. Y., Seo, H., Sonntag, K. C., Brooks, A., Lin, L., & Isacson, O. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi178 · Cited by 361
Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling
Poulin, J.-F., Zou, J., Drouin-Ouellet, J., Kim, K.-Y. A., Cicchetti, F., & Awatramani, R. B. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.008 · Cited by 352
Disentangling neural cell diversity using single-cell transcriptomics
Poulin, J.-F., Tasic, B., Hjerling-Leffler, J., Trimarchi, J. M., & Awatramani, R. (2016) · Nature Neuroscience · doi:10.1038/nn.4366 · Cited by 293
Marchitti, S. A., Deitrich, R. A., & Vasiliou, V. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.2.1 · Cited by 288
Unexpected expression of α- and β-globin in mesencephalic dopaminergic neurons and glial cells
Biagioli, M., Pinto, M., Cesselli, D., Zaninello, M., Lazarević, D., Roncaglia, P., Simone, R., Vlachouli, C., Plessy, C., Bertin, N., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813216106 · Cited by 261
Menegas, W., Babayan, B. M., Uchida, N., & Watabe‐Uchida, M. (2017) · eLife · doi:10.7554/elife.21886 · Cited by 267
Classification of midbrain dopamine neurons using single-cell gene expression profiling approaches
Poulin, J.-F., Gaertner, Z., Moreno-Ramos, O. A., & Awatramani, R. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.01.004 · Cited by 238
Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update
Brichta, L., & Greengard, P. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00152 · Cited by 227
Development of dopaminergic neurons in the mammalian brain
Prakash, N., & Wurst, W. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5387-6 · Cited by 215
Getting connected in the dopamine system
VANDENHEUVEL, D., & Pasterkamp, R. J. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.003 · Cited by 187
Chandler, D. J., Lamperski, C. S., & Waterhouse, B. D. (2013) · Brain Research · doi:10.1016/j.brainres.2013.04.057 · Cited by 168
Mandel, S. A., Grünblatt, E., Riederer, P. F., Amariglio, N., Hirsch, J. J., Rechavi, G., & Youdim, M. B. H. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1344.031 · Cited by 163
Chandler, D. J., Waterhouse, B. D., & Gao, W. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00053 · Cited by 143
Development, wiring and function of dopamine neuron subtypes
Garritsen, O., van Battum, E. Y., Grossouw, L. M., & Pasterkamp, R. J. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00669-3 · Cited by 128
Developmental origin and fate of meso-diencephalic dopamine neurons
Smits, S. M., Burbach, J. P. H., & Smidt, M. P. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.12.003 · Cited by 123
Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression
Maingay, M., Romero‐Ramos, M., Carta, M., & Kirik, D. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.007 · Cited by 121
Spatiotemporally separable Shh domains in the midbrain define distinct dopaminergic progenitor pools
Joksimovic, M., Anderegg, A., Roy, A., Campochiaro, L., Yun, B., Kittappa, R., McKay, R., & Awatramani, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904285106 · Cited by 121
Identification of neurodegenerative factors using translatome–regulatory network analysis
Brichta, L., Shin, W., Jackson-Lewis, V., Blesa, J., Yap, E.-L., Walker, Z., Zhang, J., Roussarie, J.-P., Alvarez, M. J., Califano, A., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4070 · Cited by 118
Copper and the brain noradrenergic system
Lutsenko, S., Washington-Hughes, C., Ralle, M., & Schmidt, K. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01737-3 · Cited by 108
Brimblecombe, K. R., Gracie, C. J., Platt, N. J., & Cragg, S. J. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.285890 · Cited by 106
Specification of hypothalamic neurons by dual regulation of the homeodomain protein Orthopedia
Blechman, J., Borodovsky, N., Eisenberg, M., Nabel‐Rosen, H., Grimm, J., & Levkowitz, G. (2007) · Development · doi:10.1242/dev.011262 · Cited by 104
Dopamine and Acetylcholine, a Circuit Point of View in Parkinson’s Disease
Rizzi, G., & Tan, K. R. (2017) · Frontiers in Neural Circuits · doi:10.3389/fncir.2017.00110 · Cited by 109
GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area
Reyes, S., Fu, Y., Double, K. L., Thompson, L. H., Kirik, D., Paxinos, G., & Halliday, G. M. (2012) · The Journal of Comparative Neurology · doi:10.1002/cne.23051 · Cited by 102
Kang, S. S., Ahn, E. H., Zhang, Z., Liu, X., Manfredsson, F. P., Sandoval, I. M., Dhakal, S., Iuvone, P. M., Cao, X., & Ye, K. (2018) · The EMBO Journal · doi:10.15252/embj.201798878 · Cited by 100
Individual dopamine midbrain neurons: Functional diversity and flexibility in health and disease
Liss, B., & Roeper, J. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.10.004 · Cited by 97
Dopaminergic Enhancement of Cognitive Function
Mehta, M. A., & Riedel, W. J. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777698891 · Cited by 91
Transcriptional regulation of mesencephalic dopaminergic neurons: The full circle of life and death
Alavian, K. N., Scholz, C., & Simon, H. H. (2007) · Movement Disorders · doi:10.1002/mds.21640 · Cited by 92
Molecular heterogeneity of midbrain dopaminergic neurons – Moving toward single cell resolution
Anderegg, A., Poulin, J.-F., & Awatramani, R. B. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.10.022 · Cited by 86
Filograna, R., Civiero, L., Ferrari, V., Codolo, G., Greggio, E., Bubacco, L., Beltramini, M., & Bisaglia, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136769 · Cited by 82
An Integrative Model of Effortful Control
André, N., Audiffren, M. F., & Baumeister, R. F. (2019) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2019.00079 · Cited by 96
Chandler, D. J. (2015) · Brain Research · doi:10.1016/j.brainres.2015.11.022 · Cited by 87
Kramer, D. J., Risso, D., Kosillo, P., Ngai, J., & Bateup, H. S. (2018) · eNeuro · doi:10.1523/eneuro.0152-18.2018 · Cited by 70
Differential Somatic Ca2+ Channel Profile in Midbrain Dopaminergic Neurons
Philippart, F., Destreel, G., Merino‐Sepúlveda, P., Henny, P., Engel, D., & Seutin, V. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0459-16.2016 · Cited by 68
Multiple Dopamine Systems: Weal and Woe of DopaminePreprint
Watabe‐Uchida, M., & Uchida, N. (2018) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2018.83.037648 · Cited by 71
Weisenhorn, D. M. V., Giesert, F., & Wurst, W. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13670 · Cited by 73
Functional significance of aldehyde dehydrogenase ALDH1A1 to the nigrostriatal dopamine system
Anderson, D. W., Schray, R. C., Duester, G., & Schneider, J. S. (2011) · Brain Research · doi:10.1016/j.brainres.2011.06.051 · Cited by 65
Grison, A., Zucchelli, S., Urzì, A., Zamparo, I., Lazarević, D., Pascarella, G., Roncaglia, P., Giorgetti, A., Garcia‐Esparcia, P., Vlachouli, C., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-729 · Cited by 62
Dutta, D., Ali, N., Banerjee, E., Singh, R. P., Naskar, A., Paidi, R. K., & Mohanakumar, K. P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0328-y · Cited by 59
Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression
Chung, C. Y., Koprich, J. B., Hallett, P. J., & Ole Isacson, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912193106 · Cited by 55
Rgs6 is Required for Adult Maintenance of Dopaminergic Neurons in the Ventral Substantia Nigra
Bifsha, P., Yang, J., Fisher, R. A., & Drouin, J. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004863 · Cited by 54
Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease
Greene, J. G. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.112599 · Cited by 54
The lifelong maintenance of mesencephalic dopaminergic neurons by Nurr1 and engrailed
Alavian, K. N., Jeddi, S., Naghipour, S. I., Nabili, P., Licznerski, P., & Tierney, T. S. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-27 · Cited by 53
Establishing diversity in the dopaminergic system
Bodea, G. O., & Blaess, S. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.09.016 · Cited by 50
Veenvliet, J. V., & Smidt, M. P. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1681-5 · Cited by 48
Benitez, J. A., Cheng, S., Kee, N., Cao, M., Wang, M., Deng, Q., & Hedlund, E. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.699562 · Cited by 47
Viereckel, T., Dumas, S., Smith-Anttila, C. J. A., Vlcek, B., Bimpisidis, Z., Lagerström, M. C., Konradsson-Geuken, Å., & Wallén-Mackenzie, Å. (2016) · Scientific Reports · doi:10.1038/srep35203 · Cited by 45
Lin, W., Wadlington, N. L., Chen, L., Zhuang, X., Brorson, J. R., & Kang, U. J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2286-13.2014 · Cited by 47
Li, M.-Z., Wang, J., Jiang, D., Xiang, C., Wang, F.-Y., Zhang, K., Williams, P. R., & Chen, Z. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.01.033 · Cited by 45
Gaertner, Z. A., Azcorra, M., Dombeck, D. A., & Awatramani, R. B. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105925 · Cited by 45
Biochemical premotor biomarkers for Parkinson's disease
Mollenhauer, B., & Zhang, J. (2012) · Movement Disorders · doi:10.1002/mds.24956 · Cited by 44
Filippi, A., Jainok, C., & Driever, W. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.06.010 · Cited by 43
Viemari, J., Maussion, G., Bévengut, M., Burnet, H., Pequignot, J. M., Népote, V., Pachnis, V., Simonneau, M., & Hilaire, G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04441.x · Cited by 43
Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia
Rice, M. W., Roberts, R. C., Meléndez‐Ferro, M., & Pérez‐Costas, E. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0901-y · Cited by 42
Khan, S., Stott, S. R. W., Chabrat, A., Truckenbrodt, A. M., Spencer-Dene, B., Nave, K.-A., Guillemot, F., Levesque, M., & Ang, S.-L. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2414-16.2016 · Cited by 37
The role of Pitx3 in survival of midbrain dopaminergic neurons
Smits, S. M., & Smidt, M. P. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_10 · Cited by 37
Espana, A., & Clotman, F. (2011) · The Journal of Comparative Neurology · doi:10.1002/cne.22803 · Cited by 37
Chung, C. Y., Koprich, J. B., Endo, S., & Ole Isacson, A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1972-07.2007 · Cited by 35
Schulz, D. J., Baines, R., Hempel, C. M., Li, L., Liss, B., & Misonou, H. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3194-06.2006 · Cited by 34
Human‐Specific Transcriptome of Ventral and Dorsal Midbrain Dopamine Neurons
Monzón‐Sandoval, J., Poggiolini, I., Ilmer, T., Wade‐Martins, R., Webber, C., & Parkkinen, L. (2020) · Annals of Neurology · doi:10.1002/ana.25719 · Cited by 32
Brimblecombe, K. R., Vietti‐Michelina, S., Platt, N. J., Kästli, R., Hnieno, A., Gracie, C. J., & Cragg, S. J. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00325 · Cited by 33
Jakobsson, J. E. T., Spjuth, O., & Lagerström, M. C. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab245 · Cited by 32
Smits, S. M., von Oerthel, L., Hoekstra, E. J., Burbach, J. P. H., & Smidt, M. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076037 · Cited by 31
Westerlund, M., Belin, A. C., Felder, M. R., Olson, L., & Galter, D. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05665.x · Cited by 31
Proteomics in Parkinson’s disease: current trends, translational snags and future possibilities
Srivastava, G., Singh, K., Tiwari, M. N., & Singh, M. P. (2010) · Expert Review of Proteomics · doi:10.1586/epr.09.91 · Cited by 31
Oleic Acid in the Ventral Tegmental Area Inhibits Feeding, Food Reward, and Dopamine Tone
Hryhorczuk, C., Sheng, Z., Décarie-Spain, L., Giguère, N., Ducrot, C., Trudeau, L., Routh, V. H., Alquier, T., & Fulton, S. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.203 · Cited by 33
Improved RNA preservation for immunolabeling and laser microdissection
Brown, A. L., & Smith, D. W. (2009) · RNA · doi:10.1261/rna.1733509 · Cited by 30
Sexual congruency in the connectome and translatome of VTA dopamine neurons
Chung, A. S., Miller, S. M., Sun, Y., Xu, X., & Zweifel, L. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-11478-5 · Cited by 36
del Rey, N. L., Hernández-Pinedo, N., Carrillo, M., del Cerro, M., Esteban-García, N., Trigo‐Damas, I., Monje, M. H. G., Lanciego, J. L., Cavada, C., Obeso, J. A., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00777-0 · Cited by 31
Fiorenzano, A., Sozzi, E., Parmar, M., & Storm, P. (2021) · Cells · doi:10.3390/cells10061366 · Cited by 28
O’Connell, L. A., Fontenot, M. R., & Hofmann, H. A. (2013) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2012.12.007 · Cited by 30
Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity
Tribl, F., Marcus, K., Bringmann, G., Meyer, H. E., Gerlach, M., & Riederer, P. F. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0513-7 · Cited by 29
Fiore, N. J., Tamer-Mahoney, J. D., Beheshti, A., Nieland, T. J. F., & Kaplan, D. L. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121858 · Cited by 31
Brain expression quantitative trait locus mapping informs genetic studies of psychiatric diseases
Liu, C. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1203-5 · Cited by 26
The Reticular-Activating Hypofrontality (RAH) Model of Acute Exercise
Audiffren, M. F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800778-5.00007-4 · Cited by 31
Carbone, C., Costa, A., Provensi, G., Mannaioni, G., & Masi, A. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00187 · Cited by 26
Identification of novel genes regulated in the developing human ventral mesencephalon.
Jørgensen, J. R., Juliusson, B., Henriksen, K., Hansen, C., Knudsen, S., Petersen, T., Blom, N., Seiger, A., & Wahlberg, L. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.12.023 · Cited by 26
CellMapper: rapid and accurate inference of gene expression in difficult-to-isolate cell types
Nelms, B. D., Waldron, L., Barrera, L. A., Weflen, A. W., Goettel, J. A., Guo, G., Montgomery, R. K., Neutra, M. R., Breault, D. T., Snapper, S. B., et al. (2016) · Genome biology · doi:10.1186/s13059-016-1062-5 · Cited by 24
Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson’s disease
Tan, Y., Sgobio, C., Arzberger, T., Machleid, F., Tang, Q., Findeis, E., Tost, J., Chakroun, T., Gao, P., Höllerhage, M., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02099-5 · Cited by 24
Gawęda-Walerych, K., & Żekanowski, C. (2014) · Current Genomics · doi:10.2174/1389202914666131210211033 · Cited by 23
Anisimov, S. V., Christophersen, N. S., Correia, A. S., Li, J., & Brundin, P. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-46 · Cited by 22
Age-related gene expression changes in substantia nigra dopamine neurons of the rat
Parkinson, G. M., Dayas, C. V., & Smith, D. W. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.06.002 · Cited by 21
Genetic dissection of midbrain dopamine neuron development in vivo
Ellisor, D., Rieser, C. J., Voelcker, B., Machan, J. T., & Zervas, M. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.09.019 · Cited by 20
Singh, U., Kumar, S., Shelkar, G. P., Yadav, M., Kokare, D. M., Goswami, C., Lechan, R. M., & Singru, P. S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.012 · Cited by 20
Benetti, F., Gustincich, S., & Legname, G. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.659661 · Cited by 22
Pitx3 and En1 determine the size and molecular programming of the dopaminergic neuronal pool
Kouwenhoven, W. M., von Oerthel, L., & Smidt, M. P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182421 · Cited by 19
Cavalcanti, J. R. L. D. P., de Pontes, A. L. B., Fiuza, F. P., Silva, K. D. A., Gúzen, F. P., Lucena, E. E. D. S., do Nascimento, E. S., Cavalcante, J. C., Costa, M. S. M. O., Engelberth, R. C. G. J., et al. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.05.010 · Cited by 21
Cucchiaro, G., Chaijale, N., & Commons, K. G. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.026 · Cited by 19
Zhang, X., Hu, C., Huang, C., Wei, Y., Li, X., Hu, M., Li, H., Wu, J., Czajkowsky, D. M., Guo, Y., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.853188 · Cited by 18
Evolutionary development of neural systems in vertebrates and beyond
O’Connell, L. A. (2013) · Journal of Neurogenetics · doi:10.3109/01677063.2013.789511 · Cited by 17
Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry
Wengler, K., Trujillo, P., Cassidy, C., & Horga, G. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01934-y · Cited by 18
Weber, L. M., Divecha, H. R., Tran, M. N., Kwon, S., Spangler, A., Montgomery, K. D., Tippani, M., Bharadwaj, R. A., Kleinman, J. E., Page, S. C., et al. (2023) · eLife · doi:10.7554/elife.84628 · Cited by 33
Neurotransmitter phenotype-specific expression changes in developing sympathetic neurons
Apostolova, G., Dorn, R., Ka, S., Hallböök, F., Lundeberg, J., Liser, K., Hakim, V., Brodski, C., Michaelidis, T. M., & Dechant, G. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.03.014 · Cited by 16
Horner, K. A., Gilbert, Y. E., & Cline, S. D. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00027 · Cited by 16
Endo, S. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-396456-4.00004-3 · Cited by 15
Ye, P., Fang, Q., Hu, X., Zou, W., Huang, M., Ke, M., Li, Y., Liu, M., Cai, X., Zhang, C., et al. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102530 · Cited by 14
Cardo, L. F., Monzón‐Sandoval, J., Li, Z., Webber, C., & Li, M. (2023) · Cells · doi:10.3390/cells12242860 · Cited by 16
Zhou, X., Zheng, Y., Sharma, R., & Zhang, Z. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6869350 · Cited by 14
Metadata
- Authors
- Grimm, J., Mueller, A., Hefti, F., & Rosenthal, A.
- Affiliations
- Stanford Medicine (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-09-07
- Volume
- 101
- Issue
- 38
- Pages
- 13891-13896
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC518849
- OpenAlex
- W2131058184
- Cited by
- 150
- References
- 55
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 15 · 2022: 5 · 2021: 3 · 2020: 4 · 2019: 7 · 2018: 4 · 2017: 10 · 2016: 10 · 2015: 8 · 2014: 14 · 2013: 8 · 2012: 7
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- catecholaminergic neurons, dopaminergic neurons, noradrenergic neurons, neuronal heterogeneity, gene expression profiling, locus coeruleus, substantia nigra, ventral tegmental area, midbrain dopaminergic neurons, neuroplasticity, axon guidance, schizophrenia, addiction, Parkinson's disease
- MeSH terms
- Animals, Catecholamines, Female, Gene Amplification, Hydrogen Peroxide, Neurons, RNA, Rats, Sprague-Dawley, In Situ Hybridization, Pyramidal Cells, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review